Revolution Medicines (RVMD) EBITDA Margin Growth (1y) (2020 - 2023)

Revolution Medicines (RVMD) EBITDA Margin Growth (1y) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -170.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1,276.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 1,997.00

Historic Data

Download Data
DateValue
Dec 31, 2023 -2.39 Mn
Jun 30, 2023 -216,401.00
Mar 31, 2023 -30,683.00
Dec 31, 2022 15,681.00
Sep 30, 2022 254,813.00
Jun 30, 2022 -16,908.00
Mar 31, 2022 -39,557.00
Dec 31, 2021 -16,989.00
Sep 30, 2021 -461,101.00
Jun 30, 2021 -23,287.00
Mar 31, 2021 -18,654.00
Dec 31, 2020 -22,759.00
Sep 30, 2020 -10,919.00
Jun 30, 2020 -19,315.00
Mar 31, 2020 -10,333.00